Synlait Milk (ASX:SM1) has spent 2026 rebuilding rather than expanding, and that makes it an unusual consumer staples watchlist candidate. The Canterbury-based dairy processor, dual-listed on the NZX and on the ASX since November 2016, has worked through an asset sale, a full refinancing, a change of financial year-end and a near-complete turnover of senior leadership. With full-year results due later this month and guidance already on the table, September 2026 offers an unusually clear view of the business. Market Capitalisation was about A$199 million as at 11 September 2026.

Latest Development

On 28 August 2026 Synlait issued a performance update and confirmed its FY26 results date. For the year ended 31 July 2026 the company guided to reported EBITDA of between negative NZ$2 million and positive NZ$3 million, and underlying EBITDA of NZ$36 million to NZ$41 million. Reported net loss after tax was guided to a range of NZ$70 million to NZ$75 million, with an underlying net loss of NZ$19 million to NZ$24 million.

Those ranges sit against a first half that carried a reported net loss after tax of NZ$80.6 million and a reported EBITDA loss of NZ$34.7 million, implying a materially better second half. Acting chief executive Leon Fung framed the update as evidence the recovery roadmap is taking hold. Results are scheduled for release on 28 September 2026, with a webcast that morning.

Company Overview

Synlait is a New Zealand dairy processor producing nutritional and ingredient products, with a long-standing Manufacturing relationship serving infant formula and consumer brands. It completed the sale of its North Island Assets on 2 April 2026, narrowing the operating footprint. In March 2026 it renewed its Partnership with Nestle.

Bright Dairy International Investment Limited is the major Shareholder and has provided direct financial support.

Recent Developments

The refinancing was finalised on 30 June 2026. Synlait secured NZ$320 million of bank funding across a nine-lender syndicate that includes ANZ, HSBC and Chinese banks, comprising a NZ$15 million secured overdraft, Working Capital lines totalling NZ$146 million and NZ$119 million of term loans, with maturities running through to June 2027. A replacement NZ$130 million shareholder Loan from Bright Dairy was expected to be drawn in early July 2026.

Covenants include a net senior Leverage Ratio of 3.0 times tested from June 2027 and a requirement for shareholders' funds to remain above NZ$450 million.

The board also resolved to move the balance date from 31 July to 31 December to align with Bright Dairy, creating a five-month transitional reporting period covering August to December 2026. Leadership has turned over substantially, including a chief executive resignation on 14 May 2026 and a new director appointed on 18 May 2026.

What Investors May Watch Next

The 28 September 2026 result is the obvious focus, particularly whether outcomes land inside the guided ranges and what the Balance Sheet looks like post-refinancing. Beyond that, the appointment of a permanent chief executive, the shape of the five-month transitional accounts, and progress on the recovery roadmap are identifiable markers.

Risks

Debt facilities maturing through June 2027 mean refinancing risk has been deferred rather than removed, and covenant headroom will be tested as those dates approach. Reported losses remain substantial. Dependence on a small number of large customers, milk Supply and milk price movements, currency exposure and Chinese Demand conditions all bear on earnings. Leadership instability and reliance on major shareholder funding are further considerations.

Conclusion

Synlait enters September 2026 with guidance issued, funding secured and a results date fixed — a firmer footing than the company has had for some time. Whether it earns a place on consumer staples watchlists may depend on the 28 September result confirming the second-half improvement implied by guidance, and on the permanent leadership question being resolved. The Business remains exposed to dairy pricing, customer concentration and a Debt structure that still requires attention before mid-2027.